Table 3 Determinants of the costs associated with patients with pneumococcal community-acquired pneumonia and admitted in intensive care unit, overall and among the one-year survivors
All patients (n = 1665) | Multivariable model | One-year survivors (n = 1127) | Multivariable model | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | (%) | Beta | 95% confidence interval | p Value | % of cost increase | N | (%) | Beta | 95% confidence interval | p Value | % of cost increase | |||
Intercept | 9.97 | 9.80- | 10.14 | < 0.0001 | ||||||||||
Age (years) | < 0.01 | |||||||||||||
0–54 | 394 | (24) | Ref | – | – | – | – | 322 | (29) | Ref | – | – | – | – |
55–64 | 409 | (25) | − 0.02 | − 0.12 | 0.08 | 0.7299 | 290 | (26) | 0.00 | − 0.09 | 0.10 | 0.9291 | ||
65–75 | 424 | (25) | 0.01 | − 0.09 | 0.11 | 0.7966 | 277 | (25) | 0.00 | − 0.11 | 0.10 | 0.9265 | ||
> 76 | 438 | (26) | − 0.19 | − 0.30 | − 0.09 | 0.0002 | − 17 | 238 | (21) | − 0.15 | − 0.25 | − 0.04 | 0.0075 | − 14 |
Sex (ref: women) | 1108 | (67) | 0.10 | (0.03- | 0.17) | 0.0066 | 11 | 730 | (65) | 0.07 | 0.00 | 0.15 | 0.0559 | 7 |
SAPSII initial stay | < 0.0001 | |||||||||||||
0–34 | 872 | (52) | Ref. | – | – | – | Ref | – | – | – | – | |||
35–46 | 352 | (21) | 0.20 | 0.11 | 0.29 | 0.0000 | 0.27 | 0.18 | 0.35 | < 0.0001 | 30 | |||
47–60 | 254 | (15) | 0.07 | − 0.03 | 0.17 | 0.1593 | 0.27 | 0.16 | 0.38 | < 0.0001 | 31 | |||
> 61 | 187 | (11) | − 0.21 | − 0.33 | − 0.10 | 0.0003 | 0.42 | 0.27 | 0.57 | < 0.0001 | 52 | |||
Comorbidities | ||||||||||||||
Cardiac failure | 518 | (31) | 0.14 | 0.06 | 0.22 | 0.0004 | 15 | 297 | (26) | 0.10 | 0.02 | 0.19 | 0.0189 | 11 |
Chronic respiratory diseases | 861 | (52) | 0.11 | 0.04 | 0.18 | 0.0023 | 12 | 594 | (53) | 0.10 | 0.03 | 0.18 | 0.0062 | 11 |